Groowe Groowe / Newsroom / NVO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVO News

Novo-Nordisk A/S

GLP-1 drugs associated with reduced need for emergency care for migraine

prnewswire.com
LLY NVO

Bronstein, Gewirtz & Grossman, LLC Is Investigating Novo Nordisk A/S (NVO) And Encourages Investors to Connect

accessnewswire.com
NVO

Election of employee representatives to the Board of Directors of Novo Nordisk A/S

globenewswire.com
NVO

Obesity Care Week 2026 Calls for Action to Improve Access to Obesity Care

prnewswire.com
LLY GNE REGN AMGN BSX CURX NVO ZETA

Novo Nordisk A/S - share repurchase programme

globenewswire.com
NVO

Novo Nordisk announces more than 400 million euro expansion in its manufacturing facility in Athlone, Ireland

globenewswire.com
NVO

Studies explore: GLP-1 receptor agonist use and its impact on long-term musculoskeletal health and orthopaedic surgical outcomes

prnewswire.com
NVO LLY

Bronstein, Gewirtz & Grossman, LLC Encourages Novo Nordisk A/S (NVO) Stockholders to Inquire about Securities Investigation

accessnewswire.com
NVO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO

accessnewswire.com
NVO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO

accessnewswire.com
NVO